SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Protalix BioTherapeutics, Inc. (PLX) News

Follow Protalix BioTherapeutics, Inc. (PLX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol PLX Asset equity Sector Markets 90 days 3 Last 2.9 Updated Nov 03, 2026, 11:50 AM UTC Open live news feed Open PLX chart & news
M Protalix to Report Third-Quarter Results and Business Update Nov. 10 The company said it will host a conference call and webcast at 8:00 a.m. ET. EQUITY | Nov 03, 2026, 11:50 AM UTC L HC Wainwright & Co. maintains $12.00 share target for Protalix BioTherapeutics HC Wainwright & Co. maintained a $12.00-per-share price target for Protalix BioTherapeutics, per Benzinga ratings actions. EQUITY | Sep 09, 2026, 02:55 PM UTC L PLX - Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences PLX - Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences EQUITY | Sep 08, 2026, 10:45 AM UTC L PLX Reports Q2 2026 Financial Results Protalix BioTherapeutics reports second quarter 2026 financial and business results EARNINGS | Aug 12, 2026, 10:50 AM UTC L PLX PLX PLX - Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026 - Click For PLX PLX PLX - Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026 EARNINGS | Aug 05, 2026, 10:50 AM UTC